Dynacure is a clinical-stage company focused on developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Dynacure is developing DYN101, an investigational antisense product candidate designed to reduce the expression of dynamin 2 protein for the treatment of Myotubular and Centronuclear Myopathies, in strategic collaboration with Ionis Pharmaceuticals. Dynacure is also building a complementary research portfolio targeting other orphan disorders, including its DYN201 program for the treatment of Hereditary Spastic Paraplegias. Dynacure is headquartered in Strasbourg, France with a corporate office in Philadelphia, PA, USA.
| Website | http://www.dynacure.com |
| Employees | 18 (2 on RocketReach) |
| Founded | 2016 |
| Technologies |
JavaScript
,
HTML
,
PHP
+9 more
(view full list)
|
| Industry | Biotechnology Research, Biotechnology, Science and Engineering, Life Science, Pharmaceutical, Health Care |
| Web Rank | 11 Million |
| Keywords | Life Sciences, Rare Diseases, Investigational Drugs, Clinical Stage, Drug Development, Orphan Drugs, Novel Therapies, Biotechnology, Pharmaceutical Research, Genetic Diseases, Oligonucleotide Therapeutics, Rna Therapeutics, Precision Medicine, Clinical Trials, Drug Discovery, Biopharma, Therapeutic Solutions, Medical Research, Healthcare |
| Competitors | Johnson & Johnson, Roche, Novartis, Merck & Co., Inc., Pfizer, Sanofi, AstraZeneca, Bristol Myers Squibb, Amgen, Lilly India +43 more (view full list) |
Looking for a particular Dynacure employee's phone or email?
Dynacure Questions
Belinda Cowling is the Chief Scientific Officer of Dynacure.
2 people are employed at Dynacure.
Top Dynacure Employees
-
Belinda Cowling
Chief Scientific Officer at Dynacure
Adelaide, SA, AU2 -
Dominique Nijkamp
Head of Clinical Operations at Dynacure
Vleuten, Utrecht, Netherlands11
Related Companies
